Oxidative stress-induced biomarkers for stem cell-based chemical screening

Preventive Medicine

Volumn 54, Issue SUPPL., 2012, Pages

  Yang, Se Ran ^a,b   Rahman, Irfan ^c   Trosko, James E ^d   Kang, Kyung Sun ^a,b  

^a Seoul National University   (South Korea)

^b Seoul National University   (South Korea)

^c UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

^d MICHIGAN STATE UNIVERSITY   (United States)

Author keywords

Biomarkers; Glutathione; Oxidative stress; Signal transduction; Stem cells

Indexed keywords

4 HYDROXYNONENAL; GLUTATHIONE; NITRIC OXIDE; REACTIVE OXYGEN METABOLITE; SUPEROXIDE DISMUTASE;

ADULT STEM CELL; CANCER STEM CELL; CARCINOGENESIS; CELL DIFFERENTIATION; DISEASE MARKER; EMBRYONIC STEM CELL; OXIDATIVE STRESS; PLURIPOTENT STEM CELL; PRIORITY JOURNAL; REDOX STRESS; REVIEW; SCREENING TEST; SIGNAL TRANSDUCTION; STEM CELL TRANSPLANTATION; THERAPY EFFECT;

BIOLOGICAL MARKERS; HUMANS; MASS SCREENING; OXIDATIVE STRESS; STEM CELL TRANSPLANTATION; STEM CELLS;

EID: 84860880104     PISSN: 00917435     EISSN: 10960260     Source Type: Journal    
DOI: 10.1016/j.ypmed.2011.11.013     Document Type: Review

References (138)

1. Abbas H.A., Maccio D.R., Coskun S., Jackson J.G., Hazen A.L., Sills T.M., You M.J., Hirschi K.K., Lozano G. Mdm2 is required for survival of hematopoietic stem cells/progenitors via dampening of ROS-induced p53 activity. Cell Stem Cell 2010, 7:606-617.
2. Abdel-Mageed A.S., Senagore A.J., Pietryga D.W., et al. Intravenous administration of mesenchymal stem cells genetically modified with extracellular superoxide dismutase improves survival in irradiated mice. Blood 2009, 113:1201-1203.
3. Adams G.B., Scadden D.T. A niche opportunity for stem cell therapeutics. Gene Ther. 2008, 15:96-99.
4. Armstrong L., Tilgner K., Saretzki G., et al. Human induced pluripotent stem cell lines show stress defense mechanisms and mitochondrial regulation similar to those of human embryonic stem cells. Stem Cells 2010, 28:661-673.
5. Aruoma O.I., Kang K.S., Bahorun T., Sung M.K., Rahman I. Oxidative damage and chronic inflammation induced by smoking: potential antioxidant and peripheral biomarker considerations. Cancer Prev. Res. 2005, 10:149-158.
6. Barker D.J. The developmental origins of adult disease. J. Am. Coll. Nutr. 2004, 23:588S-595S.
7. Bhandari D.R., Seo K.W., Jung J.W., et al. The regulatory role of c-MYC on HDAC2 and PcG expression in human multipotent stem cells. J. Cell Mol. Med. 2010, 15:1603-1614.
8. Bhandari D.R., Seo K.W., Roh K.H., Jung J.W., Kang S.K., Kang K.S. REX-1 expression and p38 MAPK activation status can determine proliferation/differentiation fates in human mesenchymal stem cells. PLoS One 2010, 5:e10493.
9. Bhattacharya K., Dopp E., Kakkar P., et al. Biomarkers in risk assessment of asbestos exposure. Mutat. Res. 2005, 579:6-21.
10. Bonnet D., Dick J.E. Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell. Nat. Med. 1997, 3:730-737.
11. Boulting G.L., Kiskinis E., Croft G.F., et al. A functionally characterized test set of human induced pluripotent stem cells. Nat. Biotechnol. 2011, 29:279-286.
12. Brey D.M., Motlekar N.A., Diamond S.L., Mauck R.L., Garino J.P., Burdick J.A. High-throughput screening of a small molecule library for promoters and inhibitors of mesenchymal stem cell osteogenic differentiation. Biotechnol. Bioeng. 2011, 108:163-174.
13. Bryan T.M., Reddel R.R. SV40-induced immortalization of human cells. Crit. Rev. Oncog. 1994, 5:331-357.
14. Cerutti P.A. Prooxidant states and tumor promotion. Science 1985, 227:375-381.
15. Chae H.D., Broxmeyer H.E. SIRT1-deficiency down-regulates PTEN/JNK/FOXO1 pathway to block ROS-induced apoptosis in mouse embryonic stem cells. Stem Cells Dev. 2010, 20:1277-1285.
16. Chanas S.A., Jiang Q., McMahon M., et al. Loss of the Nrf2 transcription factor causes a marked reduction in constitutive and inducible expression of the glutathione S-transferase Gsta1, Gsta2, Gstm1, Gstm2, Gstm3 and Gstm4 genes in the livers of male and female mice. Biochem. J. 2002, 365:405-416.
17. Claude N., Christakis M., Tsatsakis A.M. Stem cells technologies in toxicology assessments. Toxicology 2010, 270:1-2.
18. Coe J.P., Rahman I., Sphyris N., Clarke A.R., Harrison D.J. Glutathione and p53 independently mediate responses against oxidative stress in ES cells. Free Radic. Biol. Med. 2002, 32:187-196.
19. Couzin-Frankel J. Inflammation bares a dark side. Science 2010, 330:1621.
20. Crespo F.L., Sobrado V.R., Gomez L., Cervera A.M., McCreath K.J. Mitochondrial reactive oxygen species mediate cardiomyocyte formation from embryonic stem cells in high glucose. Stem Cells 2010, 28:1132-1142.
21. Csete M. Oxygen in the cultivation of stem cells. Ann. N. Y. Acad. Sci. 2005, 1049:1-8.
22. Desbordes S.C., Placantonakis D.G., Ciro A., et al. High-throughput screening assay for the identification of compounds regulating self-renewal and differentiation in human embryonic stem cells. Cell Stem Cell 2008, 2:602-612.
23. Dianzani M.U. 4-hydroxynonenal from pathology to physiology. Mol. Aspects Med. 2003, 24:263-272.
24. Ding S., Wu T.Y., Brinker A., et al. Synthetic small molecules that control stem cell fate. Proc. Natl. Acad. Sci. U. S. A. 2003, 100:7632-7637.
25. DiPaolo J.A. Relative difficulties in transforming human and animal cells in vitro. J. Natl. Cancer Inst. 1983, 70:3-8.
26. Edirisinghe I., Yang S.R., Yao H., et al. VEGFR-2 inhibition augments cigarette smoke-induced oxidative stress and inflammatory responses leading to endothelial dysfunction. FASEB J. 2008, 22:2297-2310.
27. Esterbauer H., Schaur R.J., Zollner H. Chemistry and biochemistry of 4-hydroxynonenal, malonaldehyde and related aldehydes. Free Radic. Biol. Med. 1991, 11:81-128.
28. Federici G., E.V., Liotta L., Edmiston K.H. Breast cancer stem cells: a new target for therapy. Oncology 2011, 25.
29. Fehrer C., Brunauer R., Laschober G., et al. Reduced oxygen tension attenuates differentiation capacity of human mesenchymal stem cells and prolongs their lifespan. Aging Cell 2007, 6:745-757.
30. Forman H.J., Dickinson D.A. Oxidative signaling and glutathione synthesis. Biofactors 2003, 17:1-12.
31. Go Y.M., Jones D.P. Redox control systems in the nucleus: mechanisms and functions. Antioxid. Redox Signal. 2010, 13:489-509.
32. Gore A., Li Z., Fung H.L., et al. Somatic coding mutations in human induced pluripotent stem cells. Nature 2011, 471:63-67.
33. Gouge R.C., Marshburn P., Gordon B.E., Nunley W., Huet-Hudson Y.M. Nitric oxide as a regulator of embryonic development. Biol. Reprod. 1998, 58:875-879.
34. Greaves M.F. Differentiation-linked leukemogenesis in lymphocytes. Science 1986, 234:697-704.
35. Guguen-Guillouzo C., Corlu A., Guillouzo A. Stem cell-derived hepatocytes and their use in toxicology. Toxicology 2010, 270:3-9.
36. Guo Y., Einhorn L., Kelley M., et al. Redox regulation of the embryonic stem cell transcription factor oct-4 by thioredoxin. Stem Cells 2004, 22:259-264.
37. Hotamisligil G.S. Inflammation and metabolic disorders. Nature 2006, 444:860-867.
38. Huang A.H., Motlekar N.A., Stein A., Diamond S.L., Shore E.M., Mauck R.L. High-throughput screening for modulators of mesenchymal stem cell chondrogenesis. Ann. Biomed. Eng. 2008, 36:1909-1921.
39. Hussein S.M., Batada N.N., Vuoristo S., et al. Copy number variation and selection during reprogramming to pluripotency. Nature 2011, 471:58-62.
40. Ieda M., Fu J.D., Delgado-Olguin P., et al. Direct reprogramming of fibroblasts into functional cardiomyocytes by defined factors. Cell 2010, 142:375-386.
41. Jang Y.Y., Sharkis S.J. A low level of reactive oxygen species selects for primitive hematopoietic stem cells that may reside in the low-oxygenic niche. Blood 2007, 110:3056-3063.
42. Ji A.R., Ku S.Y., Cho M.S., et al. Reactive oxygen species enhance differentiation of human embryonic stem cells into mesendodermal lineage. Exp. Mol. Med. 2010, 42:175-186.
43. Kao C.Y., Nomata K., Oakley C.S., Welsch C.W., Chang C.C. Two types of normal human breast epithelial cells derived from reduction mammoplasty: phenotypic characterization and response to SV40 transfection. Carcinogenesis 1995, 16:531-538.
44. Kemp K., Hares K., Mallam E., Heesom K.J., Scolding N., Wilkins A. Mesenchymal stem cell-secreted superoxide dismutase promotes cerebellar neuronal survival. J. Neurochem. 2010, 114:1569-1580.
45. Kim S.J., Lim M.S., Kang S.K., Lee Y.S., Kang K.S. Impaired functions of neural stem cells by abnormal nitric oxide-mediated signaling in an in vitro model of Niemann-Pick type C disease. Cell Res. 2008, 18:686-694.
46. Kim S.J., Park J.S., Kang K.S. Stem cells in Niemann-Pick disease. Dis. Markers 2008, 24:231-238.
47. Kim G.A., Lee S.T., Ahn J.Y., Park J.H., Lim J.M. Improved viability of freeze-thawed embryonic stem cells after exposure to glutathione. Fertil. Steril. 2010, 94:2409-2412.
48. Kim H.S., Shin T.H., Yang S.R., et al. Implication of NOD1 and NOD2 for the differentiation of multipotent mesenchymal stem cells derived from human umbilical cord blood. PLoS One 2010, 5:e15369.
49. Kim K., Doi A., Wen B., et al. Epigenetic memory in induced pluripotent stem cells. Nature 2010, 467:285-290.
50. Kovacic P., Osuna J.A. Mechanisms of anti-cancer agents: emphasis on oxidative stress and electron transfer. Curr. Pharm. Des. 2000, 6:277-309.
51. Kroon E., Martinson L.A., Kadoya K., et al. Pancreatic endoderm derived from human embryonic stem cells generates glucose-responsive insulin-secreting cells in vivo. Nat. Biotechnol. 2008, 26:443-452.
52. Kuroki T., Huh N.H. Why are human cells resistant to malignant cell transformation in vitro?. Jpn. J. Cancer Res. 1993, 84:1091-1100.
53. Kwak M.K., Itoh K., Yamamoto M., Sutter T.R., Kensler T.W. Role of transcription factor Nrf2 in the induction of hepatic phase 2 and antioxidative enzymes in vivo by the cancer chemoprotective agent, 3H-1, 2-dimethiole-3-thione. Mol. Med. 2001, 7:135-145.
54. Lau D., Ogbogu U., Taylor B., Stafinski T., Menon D., Caulfield T. Stem cell clinics online: the direct-to-consumer portrayal of stem cell medicine. Cell Stem Cell 2008, 3:591-594.
55. Lavrentieva A., Majore I., Kasper C., Hass R. Effects of hypoxic culture conditions on umbilical cord-derived human mesenchymal stem cells. Cell Commun. Signal. 2010, 8:18.
56. Lengner C.J., Gimelbrant A.A., Erwin J.A., et al. Derivation of pre-X inactivation human embryonic stem cells under physiological oxygen concentrations. Cell 2010, 141:872-883.
57. Li L., Xie T. Stem cell niche: structure and function. Annu. Rev. Cell Dev. Biol. 2005, 21:605-631.
58. Li F., He Z., Li Y., et al. Combined activin A/LiCl/Noggin treatment improves production of mouse embryonic stem cell-derived definitive endoderm cells. J. Cell Biochem. 2010, (Electronic publication ahead of print).
59. Lim M.S., Nam S.H., Kim S.J., Kang S.Y., Lee Y.S., Kang K.S. Signaling pathways of the early differentiation of neural stem cells by neurotrophin-3. Biochem. Biophys. Res. Commun. 2007, 357:903-909.
60. Lin T.M., Tsai J.L., Lin S.D., Lai C.S., Chang C.C. Accelerated growth and prolonged lifespan of adipose tissue-derived human mesenchymal stem cells in a medium using reduced calcium and antioxidants. Stem Cells Dev. 2005, 14:92-102.
61. Linning K.D., Tai M.H., Madhukar B.V., et al. Redox-mediated enrichment of self-renewing adult human pancreatic cells that possess endocrine differentiation potential. Pancreas 2004, 29:e64-e76.
62. Lister R., Pelizzola M., Kida Y.S., et al. Hotspots of aberrant epigenomic reprogramming in human induced pluripotent stem cells. Nature 2011, 471:68-73.
63. Lister R., Pelizzola M., Kida Y.S., et al. Hotspots of aberrant epigenomic reprogramming in human induced pluripotent stem cells. Nature 2011, 471:68-73.
64. Louhelainen N., Myllarniemi M., Rahman I., Kinnula V.L. Airway biomarkers of the oxidant burden in asthma and chronic obstructive pulmonary disease: current and future perspectives. Int. J. Chron. Obstruct. Pulmon. Dis. 2008, 3:585-603.
65. Mantovani A. Molecular pathways linking inflammation and cancer. Curr. Mol. Med. 2010, 10:369-373.
66. Markert C.L. Neoplasia: a disease of cell differentiation. Cancer Res. 1968, 28:1908-1914.
67. Marroquin C.E., Wai P.Y., Kuo P.C., Guo H. Redox-mediated upregulation of hepatocyte iNOS transcription requires coactivator PC4. Surgery 2005, 138:93-99.
68. Miller A.C., Samid D. Tumor resistance to oxidative stress: association with ras oncogene expression and reversal by lovastatin, an inhibitor of p21ras isoprenylation. Int. J. Cancer 1995, 60:249-254.
69. Mintz B., Illmensee K. Normal genetically mosaic mice produced from malignant teratocarcinoma cells. Proc. Natl. Acad. Sci. U. S. A. 1975, 72:3585-3589.
70. Mitchell J.D., Borasio G.D. Amyotrophic lateral sclerosis. Lancet 2007, 369:2031-2041.
71. Moneypenny C.G., Gallagher E.P. 4-Hydroxynonenal inhibits cell proliferation and alters differentiation pathways in human fetal liver hematopoietic stem cells. Biochem. Pharmacol. 2005, 69:105-112.
72. Moors M., Rockel T.D., Abel J., et al. Human neurospheres as three-dimensional cellular systems for developmental neurotoxicity testing. Environ. Health Perspect. 2009, 117:1131-1138.
73. Mora-Castilla S., Tejedo J.R., Hmadcha A., et al. Nitric oxide repression of Nanog promotes mouse embryonic stem cell differentiation. Cell Death Differ. 2010, 17:1025-1033.
74. Morrison S.J., Kimble J. Asymmetric and symmetric stem-cell divisions in development and cancer. Nature 2006, 441:1068-1074.
75. Murry C.E., Keller G. Differentiation of embryonic stem cells to clinically relevant populations: lessons from embryonic development. Cell 2008, 132:661-680.
76. Naruko T., Ueda M., Ehara S., et al. Persistent high levels of plasma oxidized low-density lipoprotein after acute myocardial infarction predict stent restenosis. Arterioscler. Thromb. Vasc. Biol. 2006, 26:877-883.
77. Pampaloni F., Reynaud E.G., Stelzer E.H. The third dimension bridges the gap between cell culture and live tissue. Nat. Rev. Mol. Cell Biol. 2007, 8:839-845.
78. Park S.B., Seo M.S., Kang J.G., Chae J.S., Kang K.S. Isolation and characterization of equine amniotic fluid-derived multipotent stem cells. Cytotherapy 2010, 13:341-349.
79. Parola M., Bellomo G., Robino G., Barrera G., Dianzani M.U. 4-Hydroxynonenal as a biological signal: molecular basis and pathophysiological implications. Antioxid. Redox Signal. 1999, 1:255-284.
80. Pasi C.E., Dereli-Oz A., Negrini S., et al. Genomic instability in induced stem cells. Cell Death Differ. 2011, 18:745-753.
81. Pera M.F. Stem cells: the dark side of induced pluripotency. Nature 2011, 471:46-47.
82. Perry G., Raina A.K., Nunomura A., Wataya T., Sayre L.M., Smith M.A. How important is oxidative damage? Lessons from Alzheimer's disease. Free Radic. Biol. Med. 2000, 28:831-834.
83. Pierce G.B. Neoplasms, differentiations and mutations. Am. J. Pathol. 1974, 77:103-118.
84. Poli G., Schaur R.J. 4-Hydroxynonenal in the pathomechanisms of oxidative stress. IUBMB Life 2000, 50:315-321.
85. Polo J.M., Liu S., Figueroa M.E., et al. Cell type of origin influences the molecular and functional properties of mouse induced pluripotent stem cells. Nat. Biotechnol. 2010, 28:848-855.
86. Potter V.R. Phenotypic diversity in experimental hepatomas: the concept of partially blocked ontogeny. The 10th Walter Hubert Lecture. Br. J. Cancer 1978, 38:1-23.
87. Potts M.B., Rola R., Claus C.P., Ferriero D.M., Fike J.R., Noble-Haeusslein L.J. Glutathione peroxidase overexpression does not rescue impaired neurogenesis in the injured immature brain. J. Neurosci. Res. 2009, 87:1848-1857.
88. Prigione A., Fauler B., Lurz R., Lehrach H., Adjaye J. The senescence-related mitochondrial/oxidative stress pathway is repressed in human induced pluripotent stem cells. Stem Cells 2010, 28:721-733.
89. Rahman I. Inflammation and the regulation of glutathione level in lung epithelial cells. Antioxid. Redox Signal. 1999, 1:425-447.
90. Rahman I. Oxidative stress, chromatin remodeling and gene transcription in inflammation and chronic lung diseases. J. Biochem. Mol. Biol. 2003, 36:95-109.
91. Rahman I. Reproducibility of oxidative stress biomarkers in breath condensate: are they reliable?. Eur. Respir. J. 2004, 23:183-184.
92. Rahman I. Regulation of glutathione in inflammation and chronic lung diseases. Mutat. Res. 2005, 579:58-80.
93. Rahman I., Adcock I.M. Oxidative stress and redox regulation of lung inflammation in COPD. Eur. Respir. J. 2006, 28:219-242.
94. Rahman I., Biswas S.K. Non-invasive biomarkers of oxidative stress: reproducibility and methodological issues. Redox Rep. 2004, 9:125-143.
95. Rahman I., Kelly F. Biomarkers in breath condensate: a promising new non-invasive technique in free radical research. Free Radic. Res. 2003, 37:1253-1266.
96. Rahman I., MacNee W. Lung glutathione and oxidative stress: implications in cigarette smoke-induced airway disease. Am. J. Physiol. 1999, 277:L1067-L1088.
97. Rahman I., Biswas S.K., Jimenez L.A., Torres M., Forman H.J. Glutathione, stress responses, and redox signaling in lung inflammation. Antioxid. Redox Signal. 2005, 7:42-59.
98. Rahman I., Yang S.R., Biswas S.K. Current concepts of redox signaling in the lungs. Antioxid. Redox Signal. 2006, 8:681-689.
99. Rajendrasozhan S., Yang S.R., Kinnula V.L., Rahman I. SIRT1, an antiinflammatory and antiaging protein, is decreased in lungs of patients with chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 2008, 177:861-870.
100. Rhim J.S. Neoplastic transformation of human cells in vitro. Crit. Rev. Oncog. 1993, 4:313-335.
101. Ruch R.J., Madhukar B.V., Trosko J.E., Klaunig J.E. Reversal of ras-induced inhibition of gap-junctional intercellular communication, transformation, and tumorigenesis by lovastatin. Mol. Carcinog. 1993, 7:50-59.
102. Saretzki G., Armstrong L., Leake A., Lako M., von Zglinicki T. Stress defense in murine embryonic stem cells is superior to that of various differentiated murine cells. Stem Cells 2004, 22:962-971.
103. Sarig R., Rotter V. Can an iPS cell secure its genomic fidelity?. Cell Death Differ. 2011, 18:743-744.
104. Scadden D.T. The stem-cell niche as an entity of action. Nature 2006, 441:1075-1079.
105. Schapira A.H. Mitochondria in the aetiology and pathogenesis of Parkinson's disease. Lancet Neurol. 2008, 7:97-109.
106. Sell S. Cellular origin of cancer: dedifferentiation or stem cell maturation arrest?. Environ. Health Perspect. 1993, 101(Suppl. 5):15-26.
107. Shimada K., Mokuno H., Matsunaga E., et al. Circulating oxidized low-density lipoprotein is an independent predictor for cardiac event in patients with coronary artery disease. Atherosclerosis 2004, 174:343-347.
108. Singh S., Vrishni S., Singh B.K., Rahman I., Kakkar P. Nrf2-ARE stress response mechanism: a control point in oxidative stress-mediated dysfunctions and chronic inflammatory diseases. Free Radic. Res. 2010, 44:1267-1288.
109. Smalley K.S., Lioni M., Herlyn M. Life isn't flat: taking cancer biology to the next dimension. In Vitro Cell. Dev. Biol. Anim. 2006, 42:242-247.
110. Smith A.G. Embryo-derived stem cells: of mice and men. Annu. Rev. Cell Dev. Biol. 2001, 17:435-462.
111. Sumi T., Tsuneyoshi N., Nakatsuji N., Suemori H. Defining early lineage specification of human embryonic stem cells by the orchestrated balance of canonical Wnt/beta-catenin, Activin/Nodal and BMP signaling. Development 2008, 135:2969-2979.
112. Tai M.H., Chang C.C., Kiupel M., Webster J.D., Olson L.K., Trosko J.E. Oct4 expression in adult human stem cells: evidence in support of the stem cell theory of carcinogenesis. Carcinogenesis 2005, 26:495-502.
113. Takahashi K., Yamanaka S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 2006, 126:663-676.
114. Till J.E. Stem cells in differentiation and neoplasia. J. Cell. Physiol. Suppl. 1982, 1:3-11.
115. Trosko J.E. The role of stem cells and gap junctional intercellular communication in carcinogenesis. J. Biochem. Mol. Biol. 2003, 36:43-48.
116. Trosko J.E. Commentary: "re-programming or selecting adult stem cells?". Stem Cell Rev. 2008, 4:81-88.
117. Trosko J.E. Human adult stem cells as the target cells for the initiation of carcinogenesis and for the generation of "Cancer Stem Cells". Int. J. Stem Cells 2008, 1:8-25.
118. Trosko J.E. Role of diet and nutrition on the alteration of the quality and quantity of stem cells in human aging and the diseases of aging. Curr. Pharm. Des. 2008, 14:2707-2718.
119. Trosko J. The gap junction as a "biological Rosetta Stone": implications of evolution, stem cells to homeostatic regulation of health and disease in the Barker hypothesis. Cell Commun. Signal. 2011, 5:53-66.
120. Trosko J.E., Kang K.S. Stem cells in toxicology: fundamental biology and practical considerations. Toxicol. Sci. 2010, 120:5269-5289.
121. Trosko J.E., Ruch R.J. Gap junctions as targets for cancer chemoprevention and chemotherapy. Curr. Drug Targets 2002, 3:465-482.
122. Trosko J., Suzuki K. Adult stem cells, the Barker Hypothesis, epigenetic events and low level radiation effects. Radiat. Health Risk Sci. 2009, 216-226.
123. Trosko J.E., Tai M.H. Adult stem cell theory of the multi-stage, multi-mechanism theory of carcinogenesis: role of inflammation on the promotion of initiated stem cells. Contrib. Microbiol. 2006, 13:45-65.
124. Trosko J.E., Upham B.L. A paradigm shift is required for the risk assessment of potential human health after exposure to low level chemical exposures: a response to the toxicity testing in the 21st century report. Int. J. Toxicol. 2010, 29:344-357.
125. Upham B.L., Trosko J.E. Oxidative-dependent integration of signal transduction with intercellular gap junctional communication in the control of gene expression. Antioxid. Redox Signal. 2009, 11:297-307.
126. Viallet J., Liu C., Emond J., Tsao M.S. Characterization of human bronchial epithelial cells immortalized by the E6 and E7 genes of human papillomavirus type 16. Exp. Cell Res. 1994, 212:36-41.
127. Vierbuchen T., Ostermeier A., Pang Z.P., Kokubu Y., Sudhof T.C., Wernig M. Direct conversion of fibroblasts to functional neurons by defined factors. Nature 2010, 463:1035-1041.
128. Wang H., Hao J., Hong C.C. Cardiac induction of embryonic stem cells by a small molecule inhibitor of Wnt/beta-catenin signaling. ACS Chem. Biol. 2010, 6:192-197.
129. Warburg O. On the origin of cancer cells. Science 1956, 123:309-314.
130. Weissman I.L., Anderson D.J., Gage F. Stem and progenitor cells: origins, phenotypes, lineage commitments, and transdifferentiations. Annu. Rev. Cell Dev. Biol. 2001, 17:387-403.
131. Wernig M., Meissner A., Foreman R., et al. In vitro reprogramming of fibroblasts into a pluripotent ES-cell-like state. Nature 2007, 448:318-324.
132. Yang S.R., Kim S.J., Byun K.H., et al. NPC1 gene deficiency leads to lack of neural stem cell self-renewal and abnormal differentiation through activation of p38 mitogen-activated protein kinase signaling. Stem Cells 2006, 24:292-298.
133. Yao H., Arunachalam G., Hwang J.W., et al. Extracellular superoxide dismutase protects against pulmonary emphysema by attenuating oxidative fragmentation of ECM. Proc. Natl. Acad. Sci. U. S. A. 2010, 107:15571-15576.
134. Yilmaz O.H., Valdez R., Theisen B.K., et al. Pten dependence distinguishes haematopoietic stem cells from leukaemia-initiating cells. Nature 2006, 441:475-482.
135. Ying Q.L., Wray J., Nichols J., et al. The ground state of embryonic stem cell self-renewal. Nature 2008, 453:519-523.
136. Yu J., Vodyanik M.A., Smuga-Otto K., et al. Induced pluripotent stem cell lines derived from human somatic cells. Science 2007, 318:1917-1920.
137. Zachar V., Prasad S.M., Weli S.C., et al. The effect of human embryonic stem cells (hESCs) long-term normoxic and hypoxic cultures on the maintenance of pluripotency. In Vitro Cell. Dev. Biol. Anim. 2010, 46:276-283.
138. Zhu S., Wurdak H., Wang J., et al. A small molecule primes embryonic stem cells for differentiation. Cell Stem Cell 2009, 4:416-426.